ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 18.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,321 | +15.7% | 4,100 | 0.0% | 0.00% | – |
Q1 2023 | $2,870 | -0.9% | 4,100 | 0.0% | 0.00% | – |
Q4 2022 | $2,895 | +189.5% | 4,100 | +1071.4% | 0.00% | – |
Q3 2022 | $1,000 | – | 350 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 350 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 350 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | -33.3% | 350 | -22.2% | 0.00% | – |
Q3 2021 | $3,000 | -25.0% | 450 | -10.0% | 0.00% | – |
Q2 2021 | $4,000 | -100.0% | 500 | -50.0% | 0.00% | – |
Q1 2021 | $8,320,000 | +207900.0% | 1,000 | +100.0% | 0.00% | – |
Q4 2020 | $4,000 | -20.0% | 500 | 0.0% | 0.00% | – |
Q3 2020 | $5,000 | -37.5% | 500 | 0.0% | 0.00% | – |
Q2 2020 | $8,000 | +100.0% | 500 | 0.0% | 0.00% | – |
Q1 2020 | $4,000 | -50.0% | 500 | 0.0% | 0.00% | – |
Q4 2019 | $8,000 | -11.1% | 500 | 0.0% | 0.00% | – |
Q3 2019 | $9,000 | -18.2% | 500 | 0.0% | 0.00% | – |
Q2 2019 | $11,000 | 0.0% | 500 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $11,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $11,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,213,326 | $18,386,000 | 10.92% |
ORACLE INVESTMENT MANAGEMENT INC | 3,776,121 | $31,417,000 | 4.70% |
GRIFFIN ASSET MANAGEMENT, INC. | 1,358,644 | $11,304,000 | 1.44% |
Selkirk Management LLC | 288,805 | $2,403,000 | 0.72% |
Chicago Capital, LLC | 1,593,126 | $13,255,000 | 0.56% |
Cannell & Co. | 1,097,419 | $9,131,000 | 0.29% |
TCI Wealth Advisors, Inc. | 55,586 | $462,000 | 0.20% |
Belpointe Asset Management LLC | 197,853 | $1,646,000 | 0.14% |
ALGERT GLOBAL LLC | 29,580 | $246,000 | 0.08% |
THOMPSON INVESTMENT MANAGEMENT, INC. | 60,900 | $507,000 | 0.08% |